Introduction
Bladder cancer begins in the bladder lining and manifests as a relatively rare type of cancer, often found quite surprisingly in older adults. Malignancy can be removed surgically or treated effectively in various innovative ways nowadays. Bladder cancer patients should vigilantly follow up with doctors after therapy because disease recurrence remains a considerable risk later on.
The phrase "advanced urothelial carcinoma" can describe both local and metastatic bladder cancer. Metastatic bladder cancer is the most advanced stage of urothelial carcinoma. Usually, urothelial carcinoma spreads to the liver, lungs, and lymph nodes in the abdomen or pelvis. It might also spread to other body components, such as the bones. While treatment can usually help manage advanced urothelial cancer and improve your quality of life, it can be challenging to cure it once it has spread to other areas entirely.
Advanced Urothelial Cancer Causes and Risk Factors:
Often, we may not exactly understand what causes urothelial carcinoma, but some factors can increase the risk, which include:
-
Consuming tobacco.
-
History of chronic kidney or ureteric inflammation.
-
Exposure to specific chemicals over time, including those used in producing rubber, paint, textiles, plastics, and colors.
-
Exposure to arsenic.
-
Previous radiation or chemotherapy for a different cancer.
-
Prolonged use of high dosages of medications.
-
Bladder cancer in the family.
-
Having Balkan nephropathy (It is a chronic kidney disease that causes kidney failure).
-
Lynch syndrome (hereditary non-polyposis colorectal cancer) is an inherited condition.
Advanced Urothelial Cancer Symptoms:
Detecting upper tract urothelial cancer early can be tricky sometimes. Also, if it grows too slowly, you may not notice any changes. Some people may have the following symptoms:
-
You might notice blood in your urine. It could be a lot or just a little.
-
A kidney or ureter blockage brings on back discomfort on one side.
-
Loss of weight.
-
Infections of the urinary tract.
Advanced Urothelial Cancer Diagnosis:
Your physician will review your medical history, conduct a physical examination, and schedule a series of tests if they suspect UTUC.
-
Urine Test
Urine cytology, a procedure used to check for cancer cells, may also require you to gather urine samples over three days.
-
Blood Test
Blood tests assess your liver and kidney function and monitor your white blood cells, red blood cells, and platelets.
-
Ultrasonography
This can provide images of your internal organs using sound waves.
-
Computed Tomography Scan
Your body's inside is scanned by specialized devices to produce images. Before the scan, you might receive a dye injection into your veins to improve the clarity of the images.
-
MRI
An MRI (magnetic resonance imaging) scan can reveal the extent of any tumors and create comprehensive cross-sectional images of your body.
-
PET Scan
During a positron emission tomography (PET) examination, modest doses of radioactive glucose are administered to the body. When scanned, cancer cells seem brighter.
-
Ureteroscopy and Cystoscopy
A ureteroscopy looks up into the ureter to the kidney, whereas a cystoscopy looks into the bladder. While a ureteroscopy is typically conducted under general anesthesia, a cystoscopy is generally performed under local anesthesia.
Current Treatment Options for Advanced Urothelial Cancer
The best treatment plan for your cancer will mainly depend on a few factors, like the specific type of cancer, its location, how aggressive it looks, and how far it has progressed. Your age, fitness level, and overall health can also play a major role.
1. Surgery
The best treatment for UTUC (upper tract urothelial cancer) is surgery. Surgery can be done openly or through a keyhole. The location and stage of the tumor determine how much surgery will be required.
2. Chemotherapy
Chemotherapy is the process of using medications to either kill or slow the growth of cancer cells. Your condition and the tumor's stage will determine how you are treated. Chemotherapy for UTUC can be given either before or following surgery. Nephroureterectomy surgery, a procedure in which the kidney and ureter are removed, occasionally involves injecting a single dose of chemotherapy "wash" into the bladder. Usually administered through a catheter kept in place for one to two weeks following surgery, this medication is termed Mitomycin. By doing this, the likelihood of bladder cancer reoccurring can be decreased.
3. Immunization
Immunotherapy for UTUC may be an option for you if your cancer has spread and is now classified as advanced or metastatic upper urothelial carcinoma. Immunotherapy works by boosting your immune system to attack the cancer cells. There is an exciting new group of medications called immunotherapy drugs or checkpoint inhibitors. Imagine them as helping your body's immune system better identify and fight those cancer cells.
4. Radiation Treatment, or Radiotherapy
Radiation therapy, sometimes called radiotherapy, kills cancer cells by using high-energy X-rays. For UTUC, however, radiation therapy is less frequently utilized.
5. Palliative Treatment
In certain instances of urothelial carcinoma of the upper tract, your healthcare team may discuss palliative care with you. Without attempting to cure cancer, palliative care seeks to enhance your quality of life by reducing its symptoms.
New Advances in Treatment for Advanced Urothelial Cancer
1. Immunotherapy
The FDA (Food and Drug Administration) authorized Nivolumab as an adjuvant treatment for patients with high-risk, muscle-invasive bladder cancer in 2021 after a clinical trial revealed that the immune checkpoint inhibitor, a form of immunotherapy that frees T cells to identify and combat tumors, doubled the median duration of cancer-free survival when compared to a placebo. In this context, adjuvant Nivolumab is currently the accepted standard of therapy.
2. Targeted Therapy
Targeted therapy is like applying the brakes on cancer. It targets specific proteins that cause cancer cells to grow, divide, and spread. Erdafitinib, the first FDA-approved targeted therapy for individuals with locally advanced or metastatic urothelial carcinoma, was approved in 2019. Some people may benefit from this medication if their malignancies contain specific mutations in the FGFR2 or FGFR3 genes. A mutation in the FGFR (fibroblast growth factor receptor) gene exists in just 20 percent of bladder tumors.
3. Photodynamic Therapy
Using this method, a light-sensitive medication builds up in cancer cells, and then laser light is activated to kill the cells. Photodynamic therapy is only effective on tumors close to the bladder lining, despite showing promise for bladder malignancies in their early stages.
Targeted Therapy for Urothelial Cancer
Targeted therapies are intended to target or disrupt the molecules or genes that cause cancer. Sometimes, the medicine will bind to the molecule it is targeting, preventing it from carrying out its intended function. In other situations, the medication will physically prevent the molecule from going where it normally goes. By preventing these molecules from doing their regular tasks, the progression of cancer can be delayed or even stopped.
Combination Treatments for Urothelial Cancer
1. Combining Chemotherapy with Immunotherapy:
Combining chemotherapy with immunotherapy to improve outcomes in metastatic urothelial carcinoma. One promising approach involves using Cisplatin-based chemotherapy alongside immune checkpoint inhibitors, aiming to enhance the body's ability to fight cancer.
2. Combining the Anticancer Drugs
When compared to normal treatment, patients with advanced urothelial cancer, the most common kind of bladder cancer, had considerably higher survival rates when the anticancer medications Enfortumab Vedotin and Pembrolizumab (EV+P) were combined.
Managing Side Effects
1. Balanced Diet
A balanced diet can meet all of a person's nutritional demands. Foods from the five groups of fruits, vegetables, grains, dairy, and protein can help control weight and lower the risk of illness.
2. Stay Hydrated
Water is a cost-effective and healthful way to stay hydrated, but other beverages can also be counted as fluid consumption.
3. Manage Side Effects
Consult a nutritionist if you suffer from nausea, appetite loss, or taste changes due to treatment. They can recommend more easily tolerated foods or supplements.
4. Protein Aids
Protein aids in tissue repair and is necessary for post-operative or therapeutic healing. Incorporate sources such as dairy, fish, legumes, and lean meat into your diet.
5. Enough Sleep
Getting enough sleep is crucial for healing. If you have trouble falling asleep because of stress or exhaustion after therapy, try creating a relaxing evening routine.
6. Bladder Health
Side effects from treatments like immunotherapy or chemotherapy can include changes in bowel or bladder function, hair loss, and nausea. Your healthcare team can provide strategies to control these side effects, so let them know about any changes or discomfort you are feeling.
7. Exercise
After therapy, bladder function may need to be managed since urothelial carcinoma affects the bladder. This could involve changing toilet habits, managing fluids, or performing pelvic floor exercises.
8. Quit Smoking
Giving up smoking can speed up your recuperation and lower your chances of developing cancer again. Smoking might impair immunity and irritate the bladder.
9. Pain Management
Discuss your choices for pain management with your healthcare provider if you are experiencing pain from surgery or treatment. This could involve prescription drugs, physical therapy, or complementary therapies like acupuncture.
Conclusion
With significant morbidity and mortality, bladder cancer is a common condition in the United States and other countries that calls for multidisciplinary medical and surgical care. Individuals with high-risk characteristics, such as smoking, extended chemical exposure, and a family history of urothelial oncology. When compared to normal treatment, individuals with advanced urothelial carcinoma had considerably higher survival rates when the anticancer medications Pembrolizumab and Enfortumab vedotin were combined.
Key Notes:
Urothelial cancer is more common in men and ranks as the tenth most common disease diagnosed globally. The primary method of diagnosing urothelial cancer is clinical presentation, followed by direct visualization by cystoscopy. Urine cytology and cystoscopy are still the gold standard for diagnosing urothelial carcinoma, even with the significant investments recently made to find urine-based assays capable of doing so. Patients with advanced urothelial carcinoma are still treated with platinum-based combination chemotherapy and immunotherapy. iCliniq emphasizes that early diagnosis and prompt treatment are the keys to well-being.
